President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.
The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years.
Access to the drugs has been limited because of their costs — around $500 a month for higher doses — and spotty insurance coverage.
Coverage of the drugs for obesity will expand to Medicare patients starting next year, according to the administration, which said some lower prices also will be phased in for patients without coverage.
Thursday’s announcement is the latest attempt by the Trump administration to rein in soaring drug prices in its efforts to address cost-of-living concerns among voters.
Still, it’s unclear how much the price drop will be felt by consumers. Drug prices can vary based on the competition for treatments and insurance coverage.
Other news we’re following:
Flight cuts hit dozens of airports Friday: The Federal Aviation Administration announced it would reduce air traffic by 10% across 40 “high-volume” markets — including New York, Los Angeles and Chicago — to maintain travel safety as air traffic controllers exhibit signs of strain during the ongoing government shutdown. See which airports will be affected.Judge orders improvements at a Chicago-area immigration facility: A federal judge on Wednesday ordered authorities to improve the facility after a group of detainees sued, alleging they were being kept in “inhumane” conditions. The order will be in effect for 14 days and requires officials to provide detainees at a U.S. Immigration and Customs Enforcement facility in the west Chicago suburb with a clean bedding mat and sufficient space to sleep, soap, towels, toilet paper, toothbrushes, toothpaste, menstrual products and prescribed medications.Supreme Court skeptical of Trump’s tariffs: Key conservative justices seemed skeptical Wednesday that Trump had the power to unilaterally impose far-reaching tariffs, potentially putting a key part of his agenda at risk. Challengers say Trump is illegally using an emergency law to claim nearly limitless tariff power and American small businesses are paying the price. Trump’s administration says the law gives the president the power to regulate importation, including tariffs.The federal government has been shut down for 37 days.